To Develop New Immunotherapies, Collaboration Is Key
Immunotherapy can backfire when a supercharged immune system attacks healthy cells, but researchers are hopeful for the future.
Rachna Shroff, MD, led a landmark study on the use of targeted drugs called PARP inhibitors in pancreatic cancer patients with BRCA mutations.
Ways to Give
Find a Physician